ابحث واعثر على CMO / CDMO الذي تحتاجه

مجالات الخبرة العلاجية (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

OEB (نطاقات التعرض المهني): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الأسواق: NMPA (China), FDA (USA)

منطقة: منطقة آسيا والمحيط الهادئ

امتثال: FDA (cGMP), ISO, NMPA (China GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

الفئة / المنتج: المواد الكيميائية الاصطناعية

خدمات: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

مجالات الخبرة العلاجية (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

منطقة: أوروبا

امتثال: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

الفئة / المنتج: المواد الكيميائية الاصطناعية

خدمات: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (نطاقات التعرض المهني): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

مجالات الخبرة العلاجية (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)

امتثال: FDA (cGMP), ISO, ECOVADIS

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

الفئة / المنتج: المواد الكيميائية الاصطناعية

خدمات: Development services, Manufacturing services

OEB (نطاقات التعرض المهني): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

منطقة: أمريكا الشمالية

الأسواق: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

امتثال: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

BSL (مستوى السلامة البيولوجية): 1, 2

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: البيولوجيا, FDF / المنتجات الدوائية

الأسواق: EMA (EU), MHRA (UK), TGA (Australia)

منطقة: أوروبا

يستخدم: Human, Veterinary

BSL (مستوى السلامة البيولوجية): 1

خدمات: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

OEB (نطاقات التعرض المهني): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

حجم الدفعة: Small, Medium

امتثال: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

الفئة / المنتج: FDF / المنتجات الدوائية

BSL (مستوى السلامة البيولوجية): 3, 1, 2

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

امتثال: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

المواد الخاضعة للرقابة: Lowest potential for abuse

OEB (نطاقات التعرض المهني): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

منطقة: أمريكا الشمالية

الفئة / المنتج: FDF / المنتجات الدوائية

الأسواق: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

BSL (مستوى السلامة البيولوجية): 1, 2

الفئة / المنتج: البيولوجيا

الأسواق: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Regulatory services

منطقة: أوروبا

امتثال: ISO

BSL (مستوى السلامة البيولوجية): 1

حجم الدفعة: Small, Medium

الفئة / المنتج: البيولوجيا

الأسواق: EMA (EU), FDA (USA), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

خدمات: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

مجالات الخبرة العلاجية (ATC): (C) Cardiovascular system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

المواد الخاضعة للرقابة: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: FDF / المنتجات الدوائية

OEB (نطاقات التعرض المهني): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

امتثال: ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human

BSL (مستوى السلامة البيولوجية): 1, 2

مجالات الخبرة العلاجية (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (N) Nervous system

الفئة / المنتج: FDF / المنتجات الدوائية

الأسواق: EMA (EU)

منطقة: أوروبا

امتثال: ISO, EMA (EU GMP)

حجم الدفعة: Large, Medium

الفئة / المنتج: المغذيات, FDF / المنتجات الدوائية

يستخدم: Veterinary

خدمات: Manufacturing services, Analytical / QC services, Regulatory services, Packaging

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

امتثال: ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

الأسواق: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MFDS (South Korea), TGA (Australia)

حجم الدفعة: Large, Medium

يستخدم: Human

الفئة / المنتج: المواد الكيميائية الاصطناعية, خدمات, FDF / المنتجات الدوائية, هندسة الجسيمات

خدمات: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

مجالات الخبرة العلاجية (ATC): (C) Cardiovascular system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

منطقة: أمريكا الشمالية

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)